Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin
Authors:
- Seong-Jang KimSKSeong-Jang Kim
- In-Ju KimIKIn-Ju Kim
- 30 April 2009
- journal article
- Published by Elsevier in European Journal of Radiology
- Vol. 70 (1) , 17-24
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Prognostic Value of Thyroglobulin Serum Levels and 131 I Whole-Body Scan after Initial Treatment of Low-Risk Differentiated Thyroid CancerThyroid®, 2004
- Positive Predictive Value of Serum Thyroglobulin Levels, Measured during the First Year of Follow-Up after Thyroid Hormone Withdrawal, in Thyroid Cancer PatientsThe Journal of Clinical Endocrinology & Metabolism, 2003
- Thyroid carcinomaThe Lancet, 2003
- Preoperative Diagnostic Value of [18F] Fluorodeoxyglucose Positron Emission Tomography in Patients With Radioiodine-Negative Recurrent Well-Differentiated Thyroid CarcinomaAnnals of Surgery, 2001
- [18F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Localizes Residual Thyroid Cancer in Patients with Negative Diagnostic 131I Whole Body Scans and Elevated Serum Thyroglobulin LevelsThe Journal of Clinical Endocrinology & Metabolism, 1999
- Papillary and Follicular Thyroid CarcinomaNew England Journal of Medicine, 1998
- PET in oncology: Will it replace the other modalities?Seminars in Nuclear Medicine, 1997
- IMAGING IN THYROID CANCEREndocrinology and Metabolism Clinics of North America, 1996
- Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancerThe Journal of Clinical Endocrinology & Metabolism, 1994
- Sequential Serum Thyroglobulin Determinations,131I Scans, and131I Uptakes After Triiodothyronine Withdrawal in Patients with Thyroid Cancer*The Journal of Clinical Endocrinology & Metabolism, 1981